文献速递骨质疏松与代谢性骨病关节外科

骨髓sFRP5水平与骨形成标志物呈负相关

Bone marrow sFRP5 level is negatively associated with bone formation markers.
PubMed 文献 · Osteoporos Int · 2016-12-17

研究纳入83例全膝关节置换术患者,前瞻性收集数据并回顾性分析,检测腰椎与股骨颈骨密度、骨髓脂肪组织sFRP5 mRNA表达、骨髓液与血清sFRP5浓度及骨转换标志物。结果显示骨髓液sFRP5浓度与骨髓脂肪组织sFRP5表达及血清sFRP5浓度正相关,骨髓脂肪组织sFRP5表达与骨密度正相关,与血清骨形成标志物P1NP负相关。结论认为骨髓sFRP5水平与骨密度及骨形成标志物密切相关,可能以旁分泌方式抑制骨形成。

要点

  • 骨髓液sFRP5浓度与骨髓脂肪组织sFRP5表达(p=0.040)及血清sFRP5浓度(p=0.043)正相关。
  • 骨髓脂肪组织sFRP5表达与腰椎及股骨颈骨密度正相关(p<0.05)。
  • 骨髓脂肪组织sFRP5与血清P1NP负相关(p=0.011),与OC、ALP亦呈负相关。

核心结论

  • 骨髓sFRP5水平与骨密度及骨形成标志物密切相关,sFRP5可能通过抑制骨形成成为骨量的潜在负向调节因子,并以旁分泌而非内分泌方式作用于骨代谢。

研究设计与样本

  • 研究纳入83例全膝关节置换术患者,前瞻性收集数据并回顾性分析,测量腰椎与股骨颈骨密度、骨髓脂肪组织sFRP5 mRNA表达、骨髓液与血清sFRP5浓度及骨形成与骨吸收标志物。

主要发现

  • 骨髓液sFRP5浓度与骨髓脂肪组织sFRP5表达正相关(p=0.040),与血清sFRP5浓度正相关(p=0.043)。
  • 骨髓脂肪组织sFRP5表达水平与骨密度呈显著正相关(p<0.05)。
  • 骨髓液sFRP5浓度与骨密度呈中度正相关但未达统计学显著。
  • 骨髓脂肪组织sFRP5与血清骨形成标志物P1NP负相关(p=0.011),与骨钙素(OC)和碱性磷酸酶(ALP)亦呈负相关。
  • 骨髓液与血清sFRP5浓度与骨形成标志物呈轻度负相关但未达统计学显著;骨吸收标志物β-胶原特殊序列(β-CTX)与sFRP5无显著相关性。

关键数值与推荐

  • 骨髓脂肪组织sFRP5 mRNA表达与骨髓脂肪组织瘦素(leptin)、过氧化物酶体增殖物激活受体γ(PPARγ)及脂联素表达正相关,其中与瘦素的相关性有统计学意义(p=0.026)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Secreted frizzled-related protein 5 (sFRP5) level in bone marrow environment is inversely correlated with bone formation markers, suggesting that it decreases bone mass by inhibiting bone formation. Besides, it functions in a local fashion when regulating bone metabolism. sFRP5 may be a target when developing anti-osteoporotic agents. INTRODUCTION: The purpose of the study is to investigate the relationship between bone marrow sFRP5 level and bone turnover state. METHODS: Eighty-three total knee arthroplasty patients were enrolled in this study. Data were collected prospectively and reviewed retrospectively. Lumbar spine and femoral neck bone mineral density (BMD), marrow adipose tissue (MAT) sFRP5 messenger RNA (mRNA) expression level, sFRP5 concentrations in marrow fluid and serum, concentrations of bone formation and resorption markers were measured for each participant. RESULTS: Marrow fluid sFRP5 concentration was positively correlated with both MAT sFRP5 expression (p = 0.040) and serum sFRP5 concentration (p = 0.043). Significantly positive correlation existed between MAT sFRP5 expression level and BMD (p < 0.05). Marrow fluid sFRP5 concentration had a moderate but not significant positive association with BMD. MAT sFRP5 was negatively related to serum bone formation markers including N-terminal propeptide of type 1 procollagen (P1NP) (p = 0.011), osteocalcin (OC), and alkaline phosphatase (ALP). Marrow fluid and serum sFRP5 concentrations also had mild negative correlations with bone formation markers but reached no significance. There was no significant correlation between bone resorption marker β-crosslaps (β-CTX) and sFRP5. The mRNA expression level of MAT sFRP5 was positively related with those of MAT leptin, peroxisome proliferator-activated receptor-γ (PPARγ), and adiponectin, and its correlation with leptin was statistically significant (p = 0.026). CONCLUSIONS: Bone marrow sFRP5 level is closely correlated with BMD and bone formation markers. sFRP5 may be a potential negative regulator of bone mass by inhibiting bone formation. It may exert its effects on bone metabolism in a paracrine, rather than endocrine manner.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Chen H, He Y, Wu D, et al. Bone marrow sFRP5 level is negatively associated with bone formation markers. Osteoporos Int. 2016. PMID: 27986984. doi:10.1007/s00198-016-3873-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。